TY  - JOUR

T1  - Cost-effectiveness of first-line immunotherapy combinations with or without chemotherapy for advanced non-small cell lung cancer: a modelling approach

JO  - BMC Cancer

UR  - http://dx.doi.org/10.1186/s12885-024-12287-6

PY  - 2024/07/22

AU  - Bullement A

AU  - Edmondson-Jones M

AU  - Latimer N

ED  - 

DO  - DOI: 10.1186/s12885-024-12287-6

PB  - Springer Science and Business Media LLC

VL  - 24

IS  - 1

SP  - 879

Y2  - 2024/12/22

ER  -